Remus Pharmaceuticals Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

63.50

45.03

24.72

18.42

11.92

Operating profit

20.04

10.55

4.07

0.76

0.39

Interest

0.32

0.23

0.09

0.04

0.04

Gross profit

23.42

11.89

4.70

1.53

1.20

EPS (Rs)

114.19

78.37

33.86

1025.80

811.60

Other income

3.69

1.58

0.72

0.81

0.85

Stock adjustment

-1.38

1.30

-0.44

-0.71

-0.40

Raw material

-

-

-

-

-

Power and fuel

-

-

-

-

-

Employee expenses

6.56

5.47

3.49

3.00

2.86

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

38.27

27.71

17.60

15.38

9.07

Provisions made

-

-

-

-

-

Depreciation

0.90

0.48

0.15

0.18

0.11

Taxation

5.71

2.91

1.16

0.33

0.28

Net profit / loss

16.82

8.50

3.39

1.03

0.81

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

1.47

1.09

1.00

0.01

0.01

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

31.57

23.42

16.47

4.14

3.29

GPM (%)

34.86

25.52

18.49

7.97

9.40

NPM (%)

25.03

18.24

13.31

5.34

6.36